# Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation

> **NCT04234932** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of the Incarnate Word** · enrollment: 10 (estimated)

## Conditions studied

- Glaucoma, Open-Angle

## Interventions

- **DRUG:** Netarsudil Ophthalmic

## Key facts

- **NCT ID:** NCT04234932
- **Lead sponsor:** University of the Incarnate Word
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-06
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04234932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04234932, "Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04234932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*